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Abstract
The formation of new transcription factor–binding sites (TFBSs) has a major impact on the evolution of gene regulatory
networks. Clearly, single nucleotide mutations arising within genomic DNA can lead to the creation of TFBSs. Are molecular
processes inducing single nucleotide mutations contributing equally to the creation of TFBSs? In the human genome,
a spontaneous deamination of methylated cytosine in the context of CpG dinucleotides results in the creation of thymine
(C / T), and this mutation has the highest rate among all base substitutions. CpG deamination has been ascribed a role in
silencing of transposons and induction of variation in regional methylation. We have previously shown that CpG deamination
created thousands of p53-binding sites within genomic sequences of Alu transposons. Interestingly, we have deﬁned
a ;30 bp region in Alu sequence, which, depending on a pattern of CpG deamination, can be converted to functional p53-,
PAX-6-, and Myc-binding sites. Here, we have studied single nucleotide mutational events leading to creation of TFBSs in
promoters of human genes and in genomic regions bound by such key transcription factors as Oct4, NANOG, and c-Myc.
We document that CpG deamination events can create TFBSs with much higher efﬁciency than other types of mutational
events. Our ﬁndings add a new role to CpG methylation: We propose that deamination of methylated CpGs constitutes one
of the evolutionary forces acting on mutational trajectories of TFBSs formation contributing to variability in gene regulation.
Key words: CpG methylation, CpG deamination, evolution of transcription factor–binding sites, evolution of gene
regulatory elements, Alu transposon.
Introduction
CpG Deamination and Evolution of Transcription
Factor–Binding Sites
The creation of transcription factor–binding sites (TFBSs) is
a fundamental evolutionary process shaping gene regula-
tory networks. Two mechanisms have been recognized
to facilitate generation of new TFBSs: insertional activity
of transposable elements resulting in spreading of TFBSs
(Bourque 2009) and mutational events. Some insight into
the robustness of the latter mechanism has been gained
in the context of evolutionary studies reporting widespread
turnover of TFBSs in mammalian genomes (Dermitzakis
and Clark 2002; Horvath et al. 2007; Odom et al. 2007;
Kasowski et al. 2010).
However, up to this point, the unequal contribution of
molecular processes inducing single nucleotide mutational
events in DNA has not been taken into account when deci-
phering evolutionary trajectories leading to creation of
TFBSs. In vertebrates, the mutation of cytosine to thymine
(C / T) in the context of CpG dinucleotides has the highest
rate among all base substitutions and is reﬂected in the on-
going genomic depletion of CpG dinucleotides. On the mo-
lecular level, this is triggered by methylation of cytosine
followed by a spontaneous deamination event creating
TpG or CpA dinucleotides (Razin and Riggs 1980).
We have previously shown that methylation and deam-
ination of CpGs embedded within Alu transposons in the
human genome resulted in generation of thousands of
p53-binding sites with the preferred core motif composed
of CpA and TpG dinucleotides (Zemojtel et al. 2009). We
reasoned that this phenomenon should not be limited to
Alu sequences and thus were expecting to gather evidence
that CpG deamination has created multiple binding sites in
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GBEmultiple regions of the human genome. Second, as CpG
deamination–driven mutagenesis is characterized by the
highest rate among all substitutions, we wanted to learn
if it is more efﬁcient in creating binding sites than the non-
deamination-driven mutagenesis. How can we deﬁne
a proper creation efﬁciency measure in this context? Here,
we address these issues and provide evidence that CpG
deamination is indeed the important evolutionary process
impacting on TFBS formation.
Materials and Methods
Ancestral Sequence Reconstruction
We reconstructed human and chimp ancestral sequences
extending a model developed by Arndt and Hwa (2005). Ini-
tially, we downloaded multiple alignments of vertebrate ge-
nomes to hg18 human genome from the University of
California–Santa Cruz (UCSC) Genome Bioinformatics Site.
In the analysis, we considered only alignments which con-
tained aligned sequences of all three species: human,
chimp, and rhesus. We extracted alignment fragments over-
lapping the putative promoter regions and the in -vivo
bound regions.
We inferred the nucleotide substitution frequencies
along the two terminal branches from the human–chimp
ancestor to human and chimp as well as the trinucleotide
distribution for the human–chimp ancestor using the max-
imum likelihood-based method developed by Duret and
Arndt (2008).
The nucleotide substitution frequencies were then used to
computethetransition probabilities of any trinucleotideatthe
human–chimp ancestor into a trinucleotide in human and
likewise in chimp. Given the states of 5# and 3# adjacent nu-
cleotides in human and their orthologous partners in chimp
and rhesus, we could then infer the ancestral nucleotide dis-
tribution of the nucleotide in the middle position. We recon-
structed ancestral nucleotides according to this distribution.
Prediction of TFBS
Position frequency matrices (PFMs) available in the Transfac
9.4 database as well as de novo proﬁles constructed from
ChIP-Seq data (Celniker et al. 2009; Kunarso et al. 2010)
were used to model binding of transcription factors.
Predictions with PFMs
We predicted binding sites using the method described by
Rahmannetal.(2003).First,basedonapositionalfrequency
matrix, we calculated a corresponding score matrix and
a cutoff threshold. Next, we scanned both strands of
a DNA sequence and checked whether it contained a motif
of a scoreat least equal to the threshold. We normalized the
thresholds for each matrix expecting the same number of
false positives within studied sequence regions.
Predictions with IUPAC Consensus Sequence
Inordertoidentifybindingsitesofc-Myctranscriptionfactor
in genome-wide ChIP-Seq regions (Zeller et al. 2006), we
used a consensus-match strategy. For a site prediction,
we demanded a perfect match to one of the two c-Myc
consensuses: CACGTG (canonical motif) and CACATG or
CATGTG (noncanonical).
Identiﬁcation of Potential Creation Events
We scanned the ancestral sequences in order to identify
‘‘potential creation events,’’ that is, all sequence locations
where a single nucleotide mutation could lead to creation
of a new TFBS. Speciﬁcally, the latter is achieved by enumer-
atingallpossiblesinglenucleotidemutationsintheancestral
sequence and then checking whether a new binding site is
predicted for the mutated sequence.




calculated how many CA or TG dinucleotides will be on av-
erage present in the predicted motifs, using the formula: P
i {f[ i,C]*f[ i þ 1, A] þ f[ i,T]*f[i þ 1, G]}, where
f(i, N) denotes the frequency of observation of nucleotide
N at position i within the PFM. We observed that on
average at least 85% of PFMs recognize a motif with CA
or TG dinucleotides.
Classiﬁcation of Putative Promoter Regions
We deﬁned putative promoter regions based on the gene
coordinates provided by EnsEMBL database (version 47).
After Weber et al. (2007), we extracted regions from 700
bp upstream to 200 bp downstream around transcription
start sites of the genes.
We classiﬁed the promoters into two groups: high CpG
set (HCP) and low CpG set (LCP) depending on their se-
quence composition. We adopted a classiﬁcation intro-
duced by Weber et al. (2007). That is, a promoter is
added to the HCP if it contains a fragment of 500 bp with
GC content larger than 0.55 and ratio of observed to ex-
pected CpG dinucleotides higher than 0.75. Moreover, if
the ratio is never larger than 0.48 for any 500 bp fragment
of a promoter, it is classiﬁed in the LCP.
Annotation of Known TF-Binding Motifs in Putative
Promoter Regions
Due to redundancies observed in the Transfac database, we
used a subset of available vertebrate PFMs. For each tran-
scription factor which has more than a single PFM assigned,
we chose only the PFM with the highest information con-
tent. This selection process resulted in a set of 217 PFMs
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tifs in the putative promoter regions.
Predicted Creation Events in the LCP and HCP Promoters
We provide two text ﬁles listing predicted TFBS creation
events in the LCP and HCP promoters (supplementary text
ﬁleS1andS2,SupplementaryMaterialonline). Thedatacol-
umns contain the following information: name of a tran-
scription factor, genomic location of the new site in the
human genome (hg18), the reconstructed ancestral
sequenceatthelocation,thecorrespondingsequenceinhu-
man hg18 genome, a list of differences/mutations between
the ancestral sequence and the corresponding human
sequence, and the list of the differences that are interpreted
as deamination events. Finally, the last column describes po-
tential single mutation events, which when occurred in the
ancestral sequence could result in a binding site. Events
marked with a star are interpreted as deamination events.
Analyses of In Vivo Bound Sequences of Oct-4, Nanog,
Ctcf, and c-Myc
Genome-wide regions bound in human embryonic stem
cells by Oct-4, Nanog, and Ctcf TFs have been identiﬁed
in the ChIP-Seq experiments described in Kunarso et al.
(2010). In total, respectively, 2.1 Mbase, 7.6 Mbase, and
7.5 Mbase of sequence alignable to chimp and rhesus ge-
nomes have been studied (supplementary table 2, Supple-
mentary Material online).
Genome-wide regions bound by the c-Myc TF in a model
human B cell line, P493 (Zeller et al. 2006) have been down-
loaded from the UCSC database (table wgEncodeGisChip-
PetMycP493 for the human genome version hg18). We
studied only regions identiﬁed by at least three independent
ChIP-PET tags. It has been demonstrated in 29 ChIP-qPCR
assays that clusters associated with at least three ChIP-PET
tags (PET-3þ) always corresponded to Myc binding (Zeller
et al. 2006). In total, we analyzed 1168 regions, which rep-
resented 1.26 Mbp of sequence alignable to chimp and
rhesus genomes.
Analyses of In Vivo Bound Sequences of TFs from
ENCODE Consortium Data Set
We downloaded from the UCSC genome browser data-
base the genome wide–binding locations of TFs identiﬁed
in conducted by the ENCODE consortium ChIP-Seq experi-
ments (in human cell lines) (Celniker et al. 2009). We used
our pipeline to calculate binding site creation efﬁciencies
for these TFs. In order to reduce estimation error of crea-
tion efﬁciencies, we selected only those experiments for
which the number of identiﬁed deamination-driven crea-
tion events or nondeamination-driven creation events
was at least 5. This resulted in evolutionary analysis of nine
TF-binding data sets (wgEncodeHudsonalphaChip-
SeqPeaks tracks: Rep2Gm12878Irf4, Rep1Gm12878Nrsf,
Rep2Gm12878Pax5n19, Rep2Gm12878Pbx3, Rep2Hepg
2RxraPcr1x, Rep1K562Usf1, and wgEncodeYaleChIPseq-
Peaks tracks: K562Nfya, K562Nfyb, and K562bYy1). The
characteristics of the ENCODE ChIP-Seq regions are
reported in (supplementary table 2, Supplementary
Material online). We used MEME algorithm to identify mo-
tifs recognized by the TFs. The identiﬁed motifs were
matched by these previously published in the Transfac da-
tabase (Transfac ID numbers: Irf4: M00972, Nfy: M00209,
NRSF: M01028, Pax5: M00143, Pbx3: M00998, Rxra:
M00518, Usf1: M00121, and YY1: M00069).
Results/Discussion
Identiﬁcation of TFBS Creation Events
In order to reveal the role of CpG deamination in TFBS for-
mation, we were interested in tracing the mutational events
that led to the creation of TFBSs in the human promoters
after the split of human and chimp. Thus, we reconstructed
the sequences of the human–chimp ancestor promoters
employing multiple sequence alignments of human, chimp,
and rhesus (see Material and Methods). In this approach,
rhesus constitutes an outgroup to infer the directionality
of mutations. Using 217 TF matrices obtained from the
TRANSFAC database (constituting a diverse repertoire of
motifs recognized by transcription factors, see Materials
and Methods), we annotated binding sites in the human
promoters and in the reconstructed human–chimp ancestor
promoters (see Material and Methods). Of all annotated
TFBSs in the human promoters, ;96.5% also get annotated
at the orthologous positions in the ancestral sequence. The
remaining ;3.5% (48861) of sites comprises a group of
candidates for TFBSs created in the human promoters since
thesplitofhumanandchimplineages.Outofthoseputative
creation events, the vast majority (;96%) was due to a sin-
gle nucleotide mutation event and thus we focused on such
creation events in our further analysis. We further subdi-
vided the single nucleotide creation events into two groups.
These are, likely ‘‘CpG deamination–driven creation events’’
encompassing CpG / CpA or TpG mutational events, ac-
counting for ;22% of all single nucleotide creation events
and ‘‘nondeamination-driven creation events’’ harboring all
other mutational events.
High Efﬁciency of CpG Deamination–Driven Creation
Events in Human Promoters
On the ﬁrst look, the CpG deamination–driven creation
events might seem to constitute a rather modest fraction
of all creation events speciﬁc to the human lineage. How-
ever, in order to interpret this result, the following has to
be taken into account. The number of TFBSs created by
CpG deamination events after the split of human and chimp
_ Zemojtel et al. GBE
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1. The mutational rate of CpGs.
2. The number and the composition of the CpG-containing
motifs residing in the human–chimp ancestral sequence.
In connection with point 2, it has to be emphasized that
CpG dinucleotides are underrepresented in the mammalian
genomes, including promoter regions (Saxonov et al. 2006).
We have thus set out to derive a new measure of a propen-
sity of CpG deamination events to create binding sites that
account for above factors. First, building on our observation
that the vast majority (96%) of creation events in the human
lineage were single nucleotide mutation events and point 2
above, we annotated all single nucleotide mutation events
that could potentially lead to creation of a TFBS within the re-
constructed human–chimp ancestral sequence. Any such mu-
tation event, we call a ‘‘potential TFBS creation event.’’
Depending on their origin, we distinguish two classes of
potential TFBS creation events: potential CpG deamination–
driven creation events (deﬁned as mutations of Cs within
CpGs) and potential nonCpG deamination–driven creation
events (encompassing all the remaining mutations). Clearly,
only a fraction of all annotated potential creation events in
the ancestral sequence occurred after the split of human
and chimp lineages. We compute this fraction by introducing
the measure of creation efﬁciency (CE). We deﬁne CEdeam for
CpG deamination–driven creation events as the ratio of the
number of CpG deamination–driven creation events that
occurred after the split of human and chimp to the number
of all potential CpG deamination–driven creation events in
the ancestral sequence.
Analogously, we deﬁne CEnondeam for nonCpG
deamination–driven creation events. How efﬁcient are
CpG deamination–driven creation events in comparison
with nondeamination–driven creation events? In order to
answer this question, we compute for each of 217 TFs
(represented by a set of 217 TF matrices) two types of
CE: CEdeam and CEnondeam. In addition, we determine aver-
age CEdeam and CEnondeam values over all 217 TFs. We per-
formed the calculation separately on two distinct classes of
human promoters (Saxonov et al. 2006) characterized by
low (LCPs) and high contents of CpG dinucleotide (HCPs).
Importantly, LCPs were shown to be mostly methylated,
whereas the vast majority of HCPs are hypomethylated in
somatic cells (Weber et al. 2007). As depicted in ﬁgure 1,
the average CEdeam value in LCPs was ;0.04 meaning that
on average 4 of 100 potential CpG deamination–driven cre-
ation events took place in LCPs. This was ;9-fold higher
than in HCPs where the average CEdeam value was
;0.005. In contrast, the average CEnondeam value was ap-
proximately equal in HCPs and LCPs (ﬁg. 1). In LCPs, CpG
deamination–driven creation events occurred ;28-fold
more frequently than nondeamination-driven creation
events, and in HCPs, we obtained a value of ;3.4-fold
enrichment. These data are compatible with a ;20.4-fold
higher rate of CpG mutation (into products of deamination
CpA or TpG) in LCPs when compared with HCPs (not
shown). In line with these observations, it has been estab-
lished that in germ line cells (the cells contributing genetic
material to the next generation), CpGs are constitutively
methylated in LCPs and, in contrast, CpGs are largely
unmethylated in HCPs (Weber et al. 2007).
These results strongly indicate that CpG deamination–
driven depletion of CpG dinucleotide, which has been rec-
ognized to contribute to variation in regional methylation
(Feinberg and Irizarry; Kerkel et al. 2008), serves as an
efﬁcient mechanism for generation of new TFBSs.
CpG Deamination Creates In Vivo Binding Sites
Since the evolutionary analysis of binding sites annotated in
the human promoter regions revealed a remarkable efﬁ-
ciencyofCpGdeamination–drivencreationevents,wewere
interested if the same could be observed for TFBSs detected
in‘‘genome-wide’’experiments.Interestingly,wefoundthat
.85% of 217 TF-binding matrices recognize on average at
least one product of deamination, CpA or TpG (Materials
and Methods) and reasoned that a large number of TFs is
capable of interacting with these dineuclotides in vivo.
We identiﬁed 13 TF-binding data sets generated in ge-
nome-wide ChIP-Seq experiments in human cells (in large
part produced by the ENCODE consortium; Celniker et al.
FIG.1 . —CpG deamination creates TFBSs with high efﬁciency in
human promoters. Each point represents a CE value calculated for each
of 217 TFs. The horizontal axis represents CE values recorded in HCPs,
and the vertical axis represents CE values obtained in LCPs. Average CE
values for CpG deamination–driven creation events (CEdeam) and
nondeamination–driven creation events (CEnondeam) are highlighted in
bold red and blue digits, respectively.
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efﬁciencies (see Materials and Methods). The 13 TFs belong
to the following major classes: helix-loop-helix/leucine zip-
per, helix-turn-helix/homeodomain/Paired box/Tryptophan
clusters, Cys2His2 zinc ﬁnger domain, Cys4 zinc ﬁnger of
nuclear type, and histone fold class. The values of CEdeam
for the 13 TFs were ;4-fold to ;25-fold higher (and on av-
erage ;11-fold higher) than the corresponding values of
CEnondeam (table 1). The latter values fall in the range
observed for the annotated binding sites in the promoter
regions (ﬁg. 1). On average, per TF, CpG deamination–
driven creation events comprised ;25% of all binding site
creation events (table 1). This all indicated that CpG
deamination events strongly contributed to creation of in
vivo TFBSs.
In the following, we illustrate the signiﬁcance of CpG
deamination–driven creation events with an evolutionary
analysis of in vivo TFBSs of such key transcription factors
as c-Myc, Nanog, Oct4, and Ctcf. It is important to note that
these factors contain CpA and TpG dinucleotides as part of
their binding motifs (ﬁg. 2A; supplementary ﬁgs. 1 and 2,
Supplementary Material online). c-Myc is known to bind
to two different E-box motifs composed of CpA, TpG,
and CpG dinucleotides: the so called canonical Myc E-box
5#-CACGTG-3# and noncanonical Myc E-box 5#-CA-
CATG-3#/5#-CATGTG-3# (Zeller et al. 2006). Our analysis
of in vivo c-Myc sites detected in a chromatin immunopre-
cipitation with the paired-end ditag experiment (ChIP-PET)
(Zeller et al. 2006) revealed that CpG deamination–driven
creation events make up as much as 56% of noncanonical
and 28% of canonical c-Myc site creation events, and as
expected, theyare localized atpositions 2, 3,4,and5 within
c-Myc motifs (ﬁg. 2A and table 1). The values of CEdeam for
canonical and noncanonical c-Myc sites were 8- and 14-fold
higher, respectively, than the values of CEnondeam. Likewise,
thestrongcontributionofCpGdeaminationeventswasalso
observed for c-Myc sites annotated in the two classes of hu-
manpromoters(supplementary table 1,SupplementaryMa-
terial online). In LCPs, CpG deamination–driven creation
events constituted as much as 78% of all noncanonical c-
Myc site creation events, and the ratio of the CEdeam and
CEnondeam values was ;51.
Moreover, we found further evidence suggesting that
CpG deamination created Myc E-box sites. Interestingly, a -
recent study reported the identiﬁcation of a canonical Myc
E-box site in AluS sequences (Wang et al. 2009). Likewise,
we identiﬁed noncanonical Myc E-box sites to reside in se-
quences of AluS transposons (ﬁg. 2B). Our literature
searches identiﬁed experimental studies in which two
canonical Myc E-box sites within AluJ and AluS elements
inserted in the second intron of the CDC25A gene
(Galaktionov et al. 1996) and in the distal promoter region
of the KIR gene (Cichocki et al. 2009), respectively, were
shown to function as Myc-responsive elements. Provoca-
tively, we found that all these canonical and noncanonical
c-Myc sites are located in one particular location in AluS/J,
which overlaps with the p53-binding site previously
described by us (Zemojtel et al. 2009)( ﬁg. 2B). The recon-
structed consensus sequences of AluS and AluJ subfamilies
contain the CGCGCG sequence at the location correspond-
ing to the Myc-binding site. Thus, we conclude that like p53
sites, they were also created via CpG deamination after the
insertion of Alu transposons into the genome. Speciﬁcally,
two and three CpG deaminations are required to create
from a CGCGCGtemplate thecanonical andthenoncanon-
ical c-Myc sites, respectively. Interestingly, it has been
Table 1
Numbers of Created In Vivo Binding Sites and Corresponding Creation Efﬁciencies
Factor dþ d  Nondþ Nond  CEdeam CEnondeam CEdeam/CEnondeam P value % of dþ
c-Myc_canonical 5 187 13 4050 0.026042 0.003200 8.0 9.4E 4 27.8
c-Myc_noncanonical 26 976 21 11706 0.025948 0.001791 14.5 3.4E 17 55.3
Ctcf 90 3356 832 199548 0.026117 0.004152 6.3 5.2E 40 9.8
Irf4 24 769 327 136133 0.030265 0.002396 12.6 1.9E 18 6.8
Nanog 70 972 246 91794 0.067178 0.002672 25.1 2.2E 111 22.2
Nfya 21 1207 50 27906 0.017101 0.001788 9.6 7.1E 13 29.6
Nfyb 22 1417 70 34235 0.015288 0.002041 7.5 9.4E 12 23.9
Nrsf 5 195 10 4207 0.025000 0.002371 10.5 3.5E 4 33.3
OCT4 33 382 99 24123 0.079518 0.004039 19.7 2.4E 29 25.0
Pax5 83 9321 244 146697 0.008826 0.001661 5.3 1.4E 29 25.4
Pbx3 10 609 35 15217 0.016155 0.002294 7.0 6.1E 6 22.2
Rxra 26 1299 83 55298 0.019622 0.001498 13.1 4.0E 19 23.8
Usf1 52 506 272 17701 0.093190 0.015134 6.2 2.1E 23 16.0
YY1 8 1354 27 19203 0.005874 0.001404 4.2 1.3E 3 22.9
NOTE.—The following values are listed: the numbers of observed new site creations due to CpG deamination events (dþ) and nondeamination events (nondþ); the numbers of
potential deamination and nondeamination-driven creation events which could lead to site creation but have not been observed (d  and nond , respectively); creation efﬁciencies for
deamination-driven creation events (CEdeam), nondeamination-driven creation events (CEnondeam), and percentages of deamination-driven creation events (% of dþ). The P value was
calculated with Fisher’s exact test.
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inthecanonicalE-boxinhibitsMycbindingbothinvitro(Pre-
ndergast et al. 1991) and in vivo (Perini et al. 2005). In light
of this, spontaneous deamination of the methylated CpG in
a canonical Myc-binding site would result in the creation of
a noncanonical-binding site, which is desensitized to meth-
ylation.
Likewise, evolutionary analysis of TFBSs of Oct4,
Nanog, and Ctcf detected in human ES cells (Kunarso
et al. 2010) also pointed to a strong contribution of CpG
FIG.2 . —CpG deamination drives creation of in vivo TFBSs. (A) Upper panel: Histogram of c-Myc- and Oct4-binding sites created via single
nucleotide mutation events. The presence of the CpA and TpG dinucleotides within individual binding sites is highlighted by a violet background. Lower
panel: Histogram of single nucleotide mutation events leading to creation of TFBSs. CpG deamination–driven creation events and non-CpG
deamination–driven creation events are depicted in red and blue, respectively. (B) PAX-6-, c-Myc-, and p53-binding sites are created via deamination of
methylated CpGs in Alu transposons. R-AluS/J_cons: consensus sequence of the CpG-containing region in the right arm of AluS and AluJ subfamilies.
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Ctcf, we obtained, respectively, a 24-, 22-, and 6-fold en-
richment of CpG deamination–driven creation events when
compared with nondeamination–driven creation events
(table 1). CpG deamination events constituted 25%,
22%, and 10% of all creation events for Oct4, Nanog,
and Ctcf, respectively (table 1 and ﬁg. 2A; supplementary
ﬁg. 3, Supplementary Material online). For example, it
can be seen that CpG deamination–driven creation events
were abundant at positions corresponding to nucleotides 4,
8, 9, and 12, where CA and TG dinucleotides are present
within the Oct4-binding motif (ﬁg. 2A, supplementary
ﬁg. 1, Supplementary Material online). We provide here ex-
perimental evidence supporting the notion that single nu-
cleotide mutations from CpG to TpG (resulting from CpG
deamination) such asseen atposition 9 in ﬁgure2A(bottom
panel) can create functional Oct4-binding motifs. Recently,
an SNP at position 9 in a putative Oct4 motif (as referenced
in ﬁg. 2A) was discovered in a patient with Beckwith–Wie-
demann syndrome (Demars et al. 2010). The mutation from
T to C occurred in the context of a TpG dinucleotide and
resulted in the creation of a CpG dinucleotide in the patient
sequence; WT: GTTTGAGATGCTAAT / P: GTTTGA-
GACGCTAAT. The study used in vitro GEMSA (Gel Electro-
phoretic Mobility Shift Assay) with nuclear extract from
Oct4-overexpressing cells to provide evidence that Oct4
did not bind to the sequence variant containing CpG (P)
but only to the one having a TpG instead of CpG.
Together, these results highlight the efﬁciency ofCpG de-
amination events in the creation of TFBS.
Originally, it has been postulated that a key role of CpG
methylation and deamination is in the inactivation of trans-
posons and thus in protecting mammalian genomes from
their insertional activity (Yoder et al. 1997; Zemach and
Zilberman 2010). One-third of all CpGs in the human ge-
nome are located within Alu transposons. Over time,
CpG deamination permanently inactivates initially CpG-rich
Alus.Asasideeffectofthisprocess,decayingAlusequences
give birth to new regulatory elements. In particular, the
CpG-rich ;20 nt long template sequence residing in Alu el-
ements(ﬁg.2B),canbeconvertedviameansofdeamination
into p53 (Zemojtel et al. 2009), PAX-6 (Zhou et al. 2002),
and c-Myc TFBSs as documented here (ﬁg. 2B).
ThisphenomenonisnotlimitedtothesethreeTFsandAlu
transposons. By analyzing mutational events leading to cre-
ation of TFBSs in human promoters (217 TFBSs) and in ge-
nome-wide regions bound in vivo (14 TFBSs), we document
that CpG deamination events create TFBSs with much high-
er efﬁciency than other single nucleotide mutational events.
In a recent study reporting genome-wide locations of Ctcf
sites in human genome, it has been noticed that ortholo-
gous Ctcf-binding sequences in vertebrate genomes accu-
mulated at a very high rate C / T mutations at the
position where the CpG dineuclotide is located in the
Ctcf-binding motif (position 15 as referenced in the supple-
mentary ﬁg. 2, Supplementary Material online) (Kim et al.
2007). This observation is compatible with CpG deamina-
tion as a driving process. In light of this, it is tempting to
speculate that CpG deamination might in fact constitute
a double-edged sword involved not only in creating but
also in inactivating binding sites. In this context, we
propose that CpG deamination, which is known to induce
variable regional methylation in human populations, con-
stitutes an evolutionary beneﬁt facilitating innovation in gene
regulation.
Supplementary Material
Supplementary ﬁgures 1–3,Supplementarytables 1and 2,and
Supplementary ﬁles 1 and 2 are available at Genome Biology
and Evolution online (http://www.gbe.oxfordjournals.org/).
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